Alexandrite vs Nd:YAG Laser Machines: Procurement Comparison
Published and reviewed by NEES Medical Editorial · Updated 2 September 2026
Direct answer
Alexandrite and long-pulsed Nd:YAG are distinct laser categories commonly identified by 755 nm and 1064 nm wavelengths. A dual-wavelength platform may include both, but buyers must confirm whether emission is selectable or simultaneous, which handpieces and cooling system are supplied, and what the exact manufacturer documentation supports.
Side-by-side procurement comparison
| Comparison point | Option one | Option two |
|---|---|---|
| Documented wavelength in IDS SMARTRION | 755 nm | 1064 nm |
| Platform identity | Alexandrite | Long-pulsed Nd:YAG |
| Buying question | How is 755 nm delivered and controlled? | How is 1064 nm delivered and controlled? |
| Shared checks | Handpiece, cooling, spot controls and training | Handpiece, cooling, spot controls and training |
Verify how dual wavelengths operate
A “dual wavelength” label is not enough. IDS states that SMARTRION can emit 755 nm and 1064 nm simultaneously. Buyers should confirm the supplied software, handpiece and operating documentation for the exact unit.
Cooling is part of the configuration
IDS lists gas or air cooling with automatic temperature control for SMARTRION. Confirm which cooling option is included, its consumables and maintenance requirements.
Do not confuse SMARTRION with Smartrion-Q
The current IDS page describes SMARTRION as Alexandrite plus long-pulsed Nd:YAG. A separately named Q-switched catalogue record requires its own manufacturer evidence and should not inherit SMARTRION specifications.
Frequently asked questions
Which wavelengths does IDS list for SMARTRION?
IDS lists 755 nm and 1064 nm for its Alexandrite and long-pulsed Nd:YAG platform.
Does dual wavelength always mean simultaneous emission?
No. Confirm the operating method in the exact manufacturer documentation. IDS specifically describes simultaneous emission for SMARTRION.
Is Smartrion-Q the same as SMARTRION?
The available catalogue descriptions conflict, so NEES Medical treats them as separate identities pending model-specific evidence.